A final study confirms the superiority of natural immunity over vaccine immunity. That’s why Pfizer…

A final study confirms the superiority of natural immunity over vaccine immunity.  That’s why Pfizer…

Recent Israeli research confirms what they have long suspected, but it does so in an interesting way, because it looks at cases from a historical perspective, and because the number of cases analyzed is enormous. Then the study was conducted in Israel, where they definitely had no prior problems with the vaccine. The study has been officially published and find it here.

It was a retrospective study, therefore on safe data, of 124,500 people, comparing two groups:

(1) SARS-CoV-2-naive individuals who received a two-dose regimen of BioNTech/Pfizer vaccine and

(ii) Previously infected individuals who have not been vaccinated.

The results are as follows:

The risk of SARS-CoV-2 vaccinations increased 13.06-fold (95% CI, 8.08–21.11) with variable delta compared to previously unvaccinated infected individuals, when the first event (infection or vaccination) occurred in January and February 2021. The increase in risk was also significant for symptomatic disease. If the infection occurred at any time between March 2020 and February 2021, evidence of naturally acquired reduced immunity has been demonstrated. Although SARS-CoV-2 vaccines still carry a 5.96-fold increased risk (95% CI, 4.85-7.33). Penetrating infection has a 7.13-fold increased risk of symptomatic disease (95% CI, 5.51-9.21).

Conclusions: Naturally acquired immunity confers stronger protection against infections and symptomatic disease caused by the delta variant of SARS-CoV-2, compared to immunity induced by the two-dose BNT162b2 vaccine.

Here we are talking about the “Delta Variant” for which the vaccine should be effective. You can imagine how effective it is against Omicron, when this alternative is studied historically.

In perspective, forced and generalized vaccination campaigns were a mistake if compared to targeted and targeted infection campaigns, which would have ensured much higher coverage. Instead, they wanted to do the opposite in Italy.

See also  Milan Stock Exchange Opens Sharply Lower, Asians Jingle - Economy

But why am I telling you? Anyway, no one cares about the scientific data.

Note: We are waiting for the surveyor’s usual fact-checker to come and challenge the matter.

Thanks to our Telegram channel, you can stay updated with new articles from economic scenarios.

⇒ record immediately


ScenariEconomici.it . Support

Among the media now fully aligned with the authority’s news releases, economic scenarios remain a voice that provides free and independent opinions. Help us grow and define ourselves, whether by sharing our content, or by making a donation if you like. Thanks!


Leave a Reply

Your email address will not be published. Required fields are marked *